# Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

> **NCT04702451** · NA · COMPLETED · sponsor: **Volta Medical** · enrollment: 377 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Dispersion ablation + PVI
- **DEVICE:** VX1
- **PROCEDURE:** PVI

## Key facts

- **NCT ID:** NCT04702451
- **Lead sponsor:** Volta Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-12
- **Primary completion:** 2023-12-27
- **Final completion:** 2023-12-27
- **Target enrollment:** 377 (ACTUAL)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04702451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04702451, "Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04702451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*